EE9800234A - Ravimeetod ja farmatseutiline kompositsioon - Google Patents
Ravimeetod ja farmatseutiline kompositsioonInfo
- Publication number
- EE9800234A EE9800234A EE9800234A EE9800234A EE9800234A EE 9800234 A EE9800234 A EE 9800234A EE 9800234 A EE9800234 A EE 9800234A EE 9800234 A EE9800234 A EE 9800234A EE 9800234 A EE9800234 A EE 9800234A
- Authority
- EE
- Estonia
- Prior art keywords
- treatment
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1132896P | 1996-02-08 | 1996-02-08 | |
| GBGB9608927.1A GB9608927D0 (en) | 1996-04-29 | 1996-04-29 | Method of treatment and pharmaceutical composition |
| PCT/US1997/001799 WO1997028797A1 (en) | 1996-02-08 | 1997-02-04 | Method of treatment and pharmaceutical composion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9800234A true EE9800234A (et) | 1998-12-15 |
Family
ID=26309231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9800234A EE9800234A (et) | 1996-02-08 | 1997-02-04 | Ravimeetod ja farmatseutiline kompositsioon |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1014972A4 (et) |
| JP (1) | JPH11504044A (et) |
| KR (1) | KR19990082367A (et) |
| CN (1) | CN1210465A (et) |
| AU (1) | AU732671B2 (et) |
| BG (1) | BG102669A (et) |
| BR (1) | BR9707369A (et) |
| CA (1) | CA2245162A1 (et) |
| CZ (1) | CZ248798A3 (et) |
| EE (1) | EE9800234A (et) |
| IL (1) | IL125446A0 (et) |
| IS (1) | IS4805A (et) |
| NO (1) | NO983641L (et) |
| NZ (1) | NZ331160A (et) |
| PL (1) | PL328074A1 (et) |
| SK (1) | SK105698A3 (et) |
| TR (1) | TR199801511T2 (et) |
| WO (1) | WO1997028797A1 (et) |
| YU (1) | YU33298A (et) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7211582B1 (en) | 1994-12-30 | 2007-05-01 | Sepracor Inc. | Methods for treating urticaria using descarboethoxyloratadine |
| US7214683B1 (en) | 1994-12-30 | 2007-05-08 | Sepracor Inc. | Compositions of descarboethoxyloratadine |
| GB9723985D0 (en) | 1997-11-14 | 1998-01-14 | Zeneca Ltd | Pharmaceutical compositions |
| CN1283115A (zh) * | 1997-12-23 | 2001-02-07 | 先灵公司 | 用于治疗呼吸道和皮肤病的含有至少一种白三烯拮抗剂和至少一种抗组胺药的组合物 |
| US6248308B1 (en) | 1998-04-14 | 2001-06-19 | Sepracor Inc. | Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma |
| US6194431B1 (en) * | 1998-04-14 | 2001-02-27 | Paul D. Rubin | Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| US6384038B1 (en) | 1998-04-14 | 2002-05-07 | Sepracor Inc. | Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants |
| ID29137A (id) * | 1998-07-27 | 2001-08-02 | Schering Corp | Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1 |
| US6262066B1 (en) | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| PA8481801A1 (es) * | 1998-09-10 | 2000-09-29 | Schering Corp | Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas |
| WO2000057880A1 (en) * | 1999-03-29 | 2000-10-05 | Schering Corporation | Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine |
| DE10007203A1 (de) * | 2000-02-17 | 2001-08-23 | Asta Medica Ag | Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis |
| AU2002227240A1 (en) * | 2000-10-30 | 2002-05-15 | Schering Corporation | Treatment and method using loratadine and montelukast |
| US20020198228A1 (en) * | 2001-04-03 | 2002-12-26 | Kaura Sita R. | Composition and method for the treatment of respiratory desease |
| WO2004087095A2 (es) * | 2003-03-31 | 2004-10-14 | Osmotica Costa Rica, Sociedad Anonima | Dispositivo osmótico que contiene zafirlukast y un antagonista h1 |
| WO2005037245A2 (en) * | 2003-10-21 | 2005-04-28 | Direct-Haler A/S | A multiple route medication for the treatment of rhinitis and asthma |
| WO2005089748A1 (en) * | 2004-03-17 | 2005-09-29 | Pfizer Limited | Combination for treating inflammatory diseases |
| US20060110449A1 (en) | 2004-10-25 | 2006-05-25 | Lorber Richard R | Pharmaceutical composition |
| TR200806298A2 (tr) * | 2008-08-22 | 2010-03-22 | Bi̇lgi̇ç Mahmut | Farmasötik formülasyon |
| EP2443134A2 (en) | 2009-06-16 | 2012-04-25 | Schering Corporation | NOVEL [3,2-c]HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF |
| KR101540191B1 (ko) * | 2014-02-24 | 2015-07-28 | 성균관대학교산학협력단 | 로라타딘을 포함하는 항염증용 조성물 |
| MA54707A (fr) * | 2019-01-10 | 2021-11-17 | Jiangyin Mucocare Pharmaceutical Co Ltd | Nouvelles formulations contenant des antagonistes des récepteurs des leucotriènes |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4282233B1 (en) * | 1980-06-19 | 2000-09-05 | Schering Corp | Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines |
| CA1261835A (en) * | 1984-08-20 | 1989-09-26 | Masaaki Toda | (fused) benz(thio)amides |
| GB8607294D0 (en) * | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
| US5565473A (en) * | 1990-10-12 | 1996-10-15 | Merck Frosst Canada, Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| US5270324A (en) * | 1992-04-10 | 1993-12-14 | Merck Frosst Canada, Inc. | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
| US5472964A (en) * | 1992-12-22 | 1995-12-05 | Merck Frosst Canada, Inc. | Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| US5595997A (en) * | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
-
1997
- 1997-02-04 PL PL97328074A patent/PL328074A1/xx unknown
- 1997-02-04 TR TR1998/01511T patent/TR199801511T2/xx unknown
- 1997-02-04 CN CN97192149A patent/CN1210465A/zh active Pending
- 1997-02-04 EP EP97905757A patent/EP1014972A4/en not_active Withdrawn
- 1997-02-04 CA CA002245162A patent/CA2245162A1/en not_active Abandoned
- 1997-02-04 IL IL12544697A patent/IL125446A0/xx unknown
- 1997-02-04 SK SK1056-98A patent/SK105698A3/sk unknown
- 1997-02-04 NZ NZ331160A patent/NZ331160A/xx unknown
- 1997-02-04 JP JP9528627A patent/JPH11504044A/ja active Pending
- 1997-02-04 AU AU22579/97A patent/AU732671B2/en not_active Ceased
- 1997-02-04 EE EE9800234A patent/EE9800234A/et unknown
- 1997-02-04 CZ CZ982487A patent/CZ248798A3/cs unknown
- 1997-02-04 KR KR1019980706097A patent/KR19990082367A/ko not_active Application Discontinuation
- 1997-02-04 WO PCT/US1997/001799 patent/WO1997028797A1/en not_active Application Discontinuation
- 1997-02-04 BR BR9707369A patent/BR9707369A/pt not_active Application Discontinuation
-
1998
- 1998-07-22 IS IS4805A patent/IS4805A/is unknown
- 1998-08-05 BG BG102669A patent/BG102669A/bg unknown
- 1998-08-06 YU YU33298A patent/YU33298A/sr unknown
- 1998-08-07 NO NO983641A patent/NO983641L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11504044A (ja) | 1999-04-06 |
| EP1014972A4 (en) | 2004-12-08 |
| PL328074A1 (en) | 1999-01-04 |
| SK105698A3 (en) | 1999-05-07 |
| BG102669A (bg) | 1999-04-30 |
| CN1210465A (zh) | 1999-03-10 |
| CZ248798A3 (cs) | 1999-01-13 |
| CA2245162A1 (en) | 1997-08-14 |
| WO1997028797A1 (en) | 1997-08-14 |
| TR199801511T2 (xx) | 1998-10-21 |
| NO983641D0 (no) | 1998-08-07 |
| YU33298A (en) | 1999-11-22 |
| BR9707369A (pt) | 1999-07-20 |
| EP1014972A1 (en) | 2000-07-05 |
| AU732671B2 (en) | 2001-04-26 |
| KR19990082367A (ko) | 1999-11-25 |
| IL125446A0 (en) | 1999-03-12 |
| NO983641L (no) | 1998-08-07 |
| NZ331160A (en) | 2000-07-28 |
| AU2257997A (en) | 1997-08-28 |
| IS4805A (is) | 1998-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9407799A (pt) | Composição de matéria método de tratamento e composição farmaceutica | |
| EE9800234A (et) | Ravimeetod ja farmatseutiline kompositsioon | |
| FI971969A0 (fi) | Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä | |
| EE03976B1 (et) | Erütromütsiinid ja nende valmistamise meetod | |
| DE69831755D1 (de) | Optoakustische kontrastmittel und anwendungsverfahren | |
| EE03966B1 (et) | Valuvaigistava toimega ühendid ja nende valmistamise meetod | |
| BR9504072A (pt) | Composiçao farmacêutica métodos para o tratamento de hipercolesterolemia de aterosclerose e kit | |
| NO994778D0 (no) | FremgangsmÕter og sammensetninger for behandling av tarmbetennelse | |
| BR9604959A (pt) | Composição e método para o tratamento de desensibilização de dentes | |
| AUPO727097A0 (en) | Method of treatment of hepatoma and pharmaceutical compositions for use therein | |
| FI971495A0 (fi) | Vaahdonestokoostumus ja sen käyttömenetelmä | |
| FI980246A (fi) | Menetelmä keittimen käyttämiseksi ja keitin | |
| EE200000226A (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
| BR9509688A (pt) | Composto e composição farmacêutica | |
| EE9800164A (et) | Farmatseutiline kompositsioon ja meetod epitelioomi raviks | |
| DE69825319D1 (de) | Präparat zur vorbeugung und behandlung von entzündungen | |
| PT932400E (pt) | Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica | |
| BR9710544A (pt) | M-todo de tratamento composto e composi-Æo farmac-utica | |
| DE69717846D1 (de) | Behandlungsverfahren von laktamen | |
| EE03687B1 (et) | Furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias | |
| DE69524527D1 (de) | AIDS-hemmende Arzneizubereitung und Verfahren | |
| FI965114A0 (fi) | Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä | |
| EP1009433A4 (en) | THERAPEUTIC COMPOSITION AND TREATMENT METHOD | |
| EE9500029A (et) | Farmatseutiline pihustatav kompositsioon ja selle saamise meetod | |
| NO20022990D0 (no) | Fremgangsmåte og sammensetning for behandling av smerte |